Chang and Chinosornvatana reported a grading system for cisplatin ototoxicity in children. This can help to identify a patient who may benefit from a change in intervention. The authors are from Stanford University and Columbia University.
Patient selection: pediatric patient receiving cisplatin chemotherapy.
Hearing Loss in dB
Frequency
Grade
<= 20
1, 2 and 4 (and 3)
0
20 to 39.9
1, 2 and 3
2b
>= 40
1
4
2, 3
3
1b
4 to 6
2a
6 to 12
1a
Hearing loss primarily in higher frequencies is seen in lower grades of hearing loss.
< =20
2
5
>=6
To read more or access our algorithms and calculators, please log in or register.
Specialty: Hematology Oncology
